Three-Dimensional Tumor Spheroids as a Tool for Reliable Investigation of Combined Gold Nanoparticle and Docetaxel Treatment
Radiotherapy and chemotherapy are the gold standard for treating patients with cancer in the clinic but, despite modern advances, are limited by normal tissue toxicity. The use of nanomaterials, such as gold nanoparticles (GNPs), to improve radiosensitivity and act as drug delivery systems can mitig...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/6/1465 |
id |
doaj-2ff3ec6de17d4d258658f598e771cbc0 |
---|---|
record_format |
Article |
spelling |
doaj-2ff3ec6de17d4d258658f598e771cbc02021-03-24T00:01:44ZengMDPI AGCancers2072-66942021-03-01131465146510.3390/cancers13061465Three-Dimensional Tumor Spheroids as a Tool for Reliable Investigation of Combined Gold Nanoparticle and Docetaxel TreatmentKyle Bromma0Abdulaziz Alhussan1Monica Mesa Perez2Perry Howard3Wayne Beckham4Devika B. Chithrani5Department of Physics and Astronomy, University of Victoria, Victoria, BC V8P 5C2, CanadaDepartment of Physics and Astronomy, University of Victoria, Victoria, BC V8P 5C2, CanadaDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, BC V8P 5C2, CanadaDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, BC V8P 5C2, CanadaDepartment of Physics and Astronomy, University of Victoria, Victoria, BC V8P 5C2, CanadaDepartment of Physics and Astronomy, University of Victoria, Victoria, BC V8P 5C2, CanadaRadiotherapy and chemotherapy are the gold standard for treating patients with cancer in the clinic but, despite modern advances, are limited by normal tissue toxicity. The use of nanomaterials, such as gold nanoparticles (GNPs), to improve radiosensitivity and act as drug delivery systems can mitigate toxicity while increasing deposited tumor dose. To expedite a quicker clinical translation, three-dimensional (3D) tumor spheroid models that can better approximate the tumor environment compared to a two-dimensional (2D) monolayer model have been used. We tested the uptake of 15 nm GNPs and 50 nm GNPs on a monolayer and on spheroids of two cancer cell lines, CAL-27 and HeLa, to evaluate the differences between a 2D and 3D model in similar conditions. The anticancer drug docetaxel (DTX) which can act as a radiosensitizer, was also utilized, informing future potential of GNP-mediated combined therapeutics. In the 2D monolayer model, the addition of DTX induced a small, non-significant increase of uptake of GNPs of between 13% and 24%, while in the 3D spheroid model, DTX increased uptake by between 47% and 186%, with CAL-27 having a much larger increase relative to HeLa. Further, the depth of penetration of 15 nm GNPs over 50 nm GNPs increased by 33% for CAL-27 spheroids and 17% for HeLa spheroids. These results highlight the necessity to optimize GNP treatment conditions in a more realistic tumor-life environment. A 3D spheroid model can capture important details, such as different packing densities from different cancer cell lines, which are absent from a simple 2D monolayer model.https://www.mdpi.com/2072-6694/13/6/1465gold nanoparticlesmulticellular spheroidsmonolayerdocetaxeluptakecell culture |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kyle Bromma Abdulaziz Alhussan Monica Mesa Perez Perry Howard Wayne Beckham Devika B. Chithrani |
spellingShingle |
Kyle Bromma Abdulaziz Alhussan Monica Mesa Perez Perry Howard Wayne Beckham Devika B. Chithrani Three-Dimensional Tumor Spheroids as a Tool for Reliable Investigation of Combined Gold Nanoparticle and Docetaxel Treatment Cancers gold nanoparticles multicellular spheroids monolayer docetaxel uptake cell culture |
author_facet |
Kyle Bromma Abdulaziz Alhussan Monica Mesa Perez Perry Howard Wayne Beckham Devika B. Chithrani |
author_sort |
Kyle Bromma |
title |
Three-Dimensional Tumor Spheroids as a Tool for Reliable Investigation of Combined Gold Nanoparticle and Docetaxel Treatment |
title_short |
Three-Dimensional Tumor Spheroids as a Tool for Reliable Investigation of Combined Gold Nanoparticle and Docetaxel Treatment |
title_full |
Three-Dimensional Tumor Spheroids as a Tool for Reliable Investigation of Combined Gold Nanoparticle and Docetaxel Treatment |
title_fullStr |
Three-Dimensional Tumor Spheroids as a Tool for Reliable Investigation of Combined Gold Nanoparticle and Docetaxel Treatment |
title_full_unstemmed |
Three-Dimensional Tumor Spheroids as a Tool for Reliable Investigation of Combined Gold Nanoparticle and Docetaxel Treatment |
title_sort |
three-dimensional tumor spheroids as a tool for reliable investigation of combined gold nanoparticle and docetaxel treatment |
publisher |
MDPI AG |
series |
Cancers |
issn |
2072-6694 |
publishDate |
2021-03-01 |
description |
Radiotherapy and chemotherapy are the gold standard for treating patients with cancer in the clinic but, despite modern advances, are limited by normal tissue toxicity. The use of nanomaterials, such as gold nanoparticles (GNPs), to improve radiosensitivity and act as drug delivery systems can mitigate toxicity while increasing deposited tumor dose. To expedite a quicker clinical translation, three-dimensional (3D) tumor spheroid models that can better approximate the tumor environment compared to a two-dimensional (2D) monolayer model have been used. We tested the uptake of 15 nm GNPs and 50 nm GNPs on a monolayer and on spheroids of two cancer cell lines, CAL-27 and HeLa, to evaluate the differences between a 2D and 3D model in similar conditions. The anticancer drug docetaxel (DTX) which can act as a radiosensitizer, was also utilized, informing future potential of GNP-mediated combined therapeutics. In the 2D monolayer model, the addition of DTX induced a small, non-significant increase of uptake of GNPs of between 13% and 24%, while in the 3D spheroid model, DTX increased uptake by between 47% and 186%, with CAL-27 having a much larger increase relative to HeLa. Further, the depth of penetration of 15 nm GNPs over 50 nm GNPs increased by 33% for CAL-27 spheroids and 17% for HeLa spheroids. These results highlight the necessity to optimize GNP treatment conditions in a more realistic tumor-life environment. A 3D spheroid model can capture important details, such as different packing densities from different cancer cell lines, which are absent from a simple 2D monolayer model. |
topic |
gold nanoparticles multicellular spheroids monolayer docetaxel uptake cell culture |
url |
https://www.mdpi.com/2072-6694/13/6/1465 |
work_keys_str_mv |
AT kylebromma threedimensionaltumorspheroidsasatoolforreliableinvestigationofcombinedgoldnanoparticleanddocetaxeltreatment AT abdulazizalhussan threedimensionaltumorspheroidsasatoolforreliableinvestigationofcombinedgoldnanoparticleanddocetaxeltreatment AT monicamesaperez threedimensionaltumorspheroidsasatoolforreliableinvestigationofcombinedgoldnanoparticleanddocetaxeltreatment AT perryhoward threedimensionaltumorspheroidsasatoolforreliableinvestigationofcombinedgoldnanoparticleanddocetaxeltreatment AT waynebeckham threedimensionaltumorspheroidsasatoolforreliableinvestigationofcombinedgoldnanoparticleanddocetaxeltreatment AT devikabchithrani threedimensionaltumorspheroidsasatoolforreliableinvestigationofcombinedgoldnanoparticleanddocetaxeltreatment |
_version_ |
1724205462153330688 |